Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
JB

John Ballantyne

North America, North Dakota, United States, Fargo

Description

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Of...

Investor Profile

John Ballantyne has backed more than 10 startups, with 2 new investments in the last 12 months alone. The firm has led 5 rounds, about 50% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Singapore.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (30%)
  • Series A (20%)
  • Series Unknown (20%)
  • Series B (10%)
  • Angel (10%)
  • Post Ipo Equity (10%)

Country Focus

  • United States (90%)
  • Singapore (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Genetics
  • Medical
  • Oncology
  • Pet
  • Veterinary
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does John Ballantyne frequently co-invest with?

Alix Ventures
Alix Ventures
North America, California, United States, San Francisco
Co-Investments: 1
KdT Ventures
KdT Ventures
North America, Texas, United States, Austin
Co-Investments: 1
GSK
GSK
North America, Pennsylvania, United States, Kelayres
Co-Investments: 1
8VC
8VC
North America, California, United States, San Francisco
Co-Investments: 1
Agilent Technologies
Agilent Technologies
North America, California, United States, Santa Clara
Co-Investments: 1
AME Cloud Ventures
AME Cloud Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Digitalis Ventures
Digitalis Ventures
North America, New York, United States, New York
Co-Investments: 1
ACVC Partners
ACVC Partners
North America, Kentucky, United States, California
Co-Investments: 1
Andreessen Horowitz
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
TC
Triatomic Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does John Ballantyne often collaborate with?

MC
Michael Chambers
North America, North Dakota, United States, Fargo
Shared Deals: 1
MC
Shared Deals: 1
JE
Shared Deals: 1

What are some of recent deals done by John Ballantyne?

VerImmune

Baltimore, Maryland, United States

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

BiotechnologyHealth CareOncologyTherapeutics
SeedSep 23, 2024
Amount Raised: $4,500,000
GlucoTrack

Rutherford, New Jersey, United States

GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices.

Health CareManufacturingMedical DeviceWellness
Post Ipo EquityJul 31, 2024
Amount Raised: $4,000,000
Elegen

San Carlos, California, United States

Elegen is a biotechnology company that develops microfluidic technology.

BiotechnologyHealth CareLife Science
Series BMay 14, 2024
Amount Raised: $35,000,000
Thrixen

Singapore, Central Region, Singapore

Diagnotics, IVD, Point of Care,

BiotechnologyHealth Diagnostics
Series UnknownApr 29, 2024
Amount Raised: $7,000,000
Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series ANov 3, 2023
Amount Raised: $11,703,095
JURA Bio

Somerville, Massachusetts, United States

Jura Bio is a therapeutics company focused on translating successes in CAR-T to autoimmune disorders.

BiotechnologyGeneticsHealth CareLife ScienceTherapeutics
SeedSep 21, 2023
Amount Raised: $16,100,000
CureLab Oncology

Boston, Massachusetts, United States

CureLab Oncology is a biotechnology company developing revolutionary therapies for oncology patients.

BiotechnologyHealth CareOncologyTherapeutics
Series UnknownDec 22, 2022
Amount Raised: $3,000,000
Myosana Therapeutics

Seattle, Washington, United States

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.

BiotechnologyTherapeutics
SeedDec 7, 2022
Amount Raised: $5,000,000
Curelab Veterinary

Boston, Massachusetts, United States

Curelab Veterinary operates as an animal-health company that specializes in treating breast cancer in dogs and cats.

Health CareMedicalPetVeterinary
AngelNov 21, 2022
Amount Raised: $2,500,000
Kytopen

Cambridge, Massachusetts, United States

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

BiotechnologyGeneticsHealth CareLife Science
Series ASep 28, 2021
Amount Raised: $30,000,000

Find More Investors Like John Ballantyne

Discover similar investors in our database and build your perfect investor list.

series_a InvestorsInvestors in FargoBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors
John Ballantyne | Pipeseed